Main > A1. CORP. INDEX. A-Am No. 1 > Acadia Pharmaceuticals/P C2



Acadia Pharmaceuticals/P C2's subsections
2008. 08.11. WorkForce Redn.
2011. 11.07. Schizophrenia
2012. 01.30. BoD
2012. 03.05. Allergan
2012. 03.27. Neuro.>PD
2014. 09.02. Neuro.>PD>PDP Phase 3
2016. 05.31. Neuro.>PD>PDP USA>OK
2018. 06.29. Neuro.>PD>PDP USA>OK
2020. 08.25. Acq. CerSci Therapeuti
2023. 03.10. U.S. FDA Approval
Web-Site

Acadia Pharmaceuticals/P C2's products
This section has no products